These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32525876)

  • 1. Inclusion of women susceptible to and becoming pregnant in preregistration clinical trials in low- and middle-income countries: A proposal for neglected tropical diseases.
    Couderc-Pétry M; Eléfant E; Wasunna M; Mwinga A; Kshirsagar NA; Strub-Wourgaft N
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008140. PubMed ID: 32525876
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving access to medicines for neglected tropical diseases in developing countries: lessons from three emerging economies.
    Holt F; Gillam SJ; Ngondi JM
    PLoS Negl Trop Dis; 2012; 6(2):e1390. PubMed ID: 22389728
    [No Abstract]   [Full Text] [Related]  

  • 3. Fostering innovative product development for neglected tropical diseases through partnerships.
    Starr A; Graef KM; Dent J
    Pharm Pat Anal; 2016 Sep; 5(6):391-400. PubMed ID: 27813447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebos and HIV. Lessons learned.
    Levine C
    Hastings Cent Rep; 1998; 28(6):43-8. PubMed ID: 9868611
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel therapeutic approaches for neglected infectious diseases.
    Martin-Plaza J; Chatelain E
    J Biomol Screen; 2015 Jan; 20(1):3-5. PubMed ID: 25542923
    [No Abstract]   [Full Text] [Related]  

  • 6. Advancing Sino-Indian cooperation to combat tropical diseases.
    Hotez P; Singh SK; Zhou XN
    PLoS Negl Trop Dis; 2013; 7(9):e2204. PubMed ID: 24086775
    [No Abstract]   [Full Text] [Related]  

  • 7. Inclusion of women in clinical trials of antiretroviral agents for HIV/AIDS during pregnancy.
    Mangino JE; Fass RJ
    Lancet; 1997 Jul; 350(9071):150. PubMed ID: 9228998
    [No Abstract]   [Full Text] [Related]  

  • 8. Neglected tropical diseases and infectious illnesses: potential targeted peptides employed as hits compounds in drug design.
    Silva JV; Santos SDS; Machini MT; Giarolla J
    J Drug Target; 2021 Mar; 29(3):269-283. PubMed ID: 33059502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should research ethics change at the border?
    McNeill PM
    Med J Aust; 1998 Nov; 169(10):509-10. PubMed ID: 9861904
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of neglected tropical disease drug and vaccine development pipelines to predict issuance of FDA priority review vouchers over the next decade.
    Stefanakis R; Robertson AS; Ponder EL; Moree M
    PLoS Negl Trop Dis; 2012; 6(10):e1803. PubMed ID: 23145186
    [No Abstract]   [Full Text] [Related]  

  • 11. AZT trials and tribulations.
    Crouch RA; Arras JD
    Hastings Cent Rep; 1998; 28(6):26-34. PubMed ID: 9868608
    [No Abstract]   [Full Text] [Related]  

  • 12. Harnessing genomics in the battle against antimicrobial resistance and neglected tropical diseases.
    Dance DAB; Batty EM
    EBioMedicine; 2021 Jan; 63():103178. PubMed ID: 33340997
    [No Abstract]   [Full Text] [Related]  

  • 13. Inclusion of pregnant women in clinical trials of COVID-19 therapies: what have we learned?
    Einav S; Ippolito M; Cortegiani A
    Br J Anaesth; 2020 Sep; 125(3):e326-e328. PubMed ID: 32532425
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World.
    Merson MH
    N Engl J Med; 1998 Mar; 338(12):836; author reply 840-1. PubMed ID: 9508627
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethical complexities of conducting research in developing countries.
    Varmus H; Satcher D
    N Engl J Med; 1997 Oct; 337(14):1003-5. PubMed ID: 9309109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseases.
    Sheean ME; Malikova E; Duarte D; Capovilla G; Fregonese L; Hofer MP; Magrelli A; Mariz S; Mendez-Hermida F; Nistico R; Leest T; Sipsas NV; Tsigkos S; Vitezic D; Larsson K; Sepodes B; Stoyanova-Beninska V
    Drug Discov Today; 2020 Feb; 25(2):274-291. PubMed ID: 31704277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action.
    Taylor MM; Kobeissi L; Kim C; Amin A; Thorson AE; Bellare NB; Brizuela V; Bonet M; Kara E; Thwin SS; Kuganantham H; Ali M; Oladapo OT; Broutet N
    Lancet Glob Health; 2021 Mar; 9(3):e366-e371. PubMed ID: 33340453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income country.
    Cutland CL; Cunnington M; Olugbosi M; Jones SA; Hugo A; Maharaj K; Slobod K; Madhi SA
    Vaccine; 2015 Nov; 33(47):6406-12. PubMed ID: 26409812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Science in the service of healing.
    Grady C
    Hastings Cent Rep; 1998; 28(6):34-8. PubMed ID: 9868609
    [No Abstract]   [Full Text] [Related]  

  • 20. The ethics of placebo-controlled trials for perinatal transmission of HIV in developing countries.
    Clark PA
    J Clin Ethics; 1998; 9(2):156-66. PubMed ID: 9750987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.